4/A: Modular Medical Director Duane M. DeSisto Reports Transaction
SEC Form 4/A
Duane M. DeSisto, a director at Modular Medical, Inc., reports the acquisition and disposal of common stock.
Summary
- Duane M. DeSisto, a director of Modular Medical, Inc. (MODD), filed an amended Form 4 on July 2, 2024, reporting changes in beneficial ownership.
- The report details a transaction on September 30, 2023, where DeSisto acquired 2,390 shares of common stock.
- Following the reported transaction, DeSisto beneficially owns 252,390 shares.
- The shares include restricted stock units (RSUs) granted on July 5, 2023, which vest quarterly over three years.
- The issuer issued shares to the reporting person in accordance with its Outside Director Compensation Plan.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing detailing a director's stock transactions, indicating a neutral sentiment.
Industry Context
This filing is a routine disclosure related to insider transactions and is required by the SEC to ensure transparency in the market.
Stakeholder Impact
- The transaction may be of interest to shareholders as it provides insight into the actions of a company director.
Key Dates
| Date | Description |
|---|---|
| 07/05/2023 | Restricted stock units (RSUs) granted to the Reporting Person |
| 09/30/2023 | Date of transaction: acquisition of 2,390 shares of common stock |
| 10/03/2023 | Date of Original Filed (Month/Day/Year) |
| 07/02/2024 | Date of signature on the report |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.